U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase the proportion of people who get a kidney transplant within 3 years of end-stage kidney disease treatment — CKD‑09 Data Methodology and Measurement

On this page:  About the National Data  |  Methodology  |  History

About the National Data

Data

Data Source:  United States Renal Data System (USRDS), NIH/NIDDK

Baseline: 12.4 percent of end-stage kidney patients under 70 years received a kidney transplant within 3 years of initiating treatment for ESKD in 2013

Target: 19.7 percent

Numerator
Number of persons under 70 years receiving a kidney transplant within 3 years of initiating treatment for ESKD.
Denominator
Number of persons under 70 years beginning treatment for ESKD in a year.
Target-setting method
Percentage point improvement
Target-setting method details
Percentage point improvement from the baseline using Cohen's h effect size of 0.20.
1
Target-setting method justification
Trend data were evaluated for this objective but it was not possible to project a target because the target was moving away from the desired direction. A percentage point improvement was calculated using Cohen's h effect size of 0.2. This method was used because data for this objective have been steadily declining, reflecting scarcity of donor organs. Dramatic changes to organ allocation were implemented in 2014 aimed at increasing organ availability but are not yet available and thus past trends are both unreliable and undesirable in predicting future goals. The Healthy People 2030 Workgroup Subject Matter Experts expected that significant improvements can be achieved.

Methodology

Methodology notes

Data on the number of persons on transplant waiting lists include data from the Organ Procurement and Transplant Network and the United Network for Organ Sharing. Data include patients younger than age 70 at ESKD certification. Patients are followed for three years, from ESKD certification until death, transplant, or censoring at three years post-transplant. Percentages are calculated using the Kaplan-Meier methodology.

History

Comparable HP2020 objective
Retained, which includes core objectives that are continuing from Healthy People 2020 with no change in measurement.
Revision History
Revised. 

In 2021, the original baseline was revised from 12.7 to 12.4 percent due to USRDS rates re-estimation. There is some lag in reporting new cases of ESRD. Therefore, each year's Annual Data Report includes re-estimates of earlier year rates. For more information see the USRDS Annual Data Reports. The target was adjusted from 20.1 to 19.7 percent to reflect the revised baseline using the original target-setting method.

1. Effect size h=0.2 was chosen to correspond with 20% improvement from a baseline of 50%.